Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study
- Status
- TERMINATED
- Phase
- PHASE3
Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2